Docetaxel-loaded exosomes for targeting non-small cell lung cancer: preparation and evaluation in vitro and in vivo

Non-small cell lung cancer (NSCLC) is a highly lethal disease and the majority of NSCLC patients are desperate for therapies that can effectively target their cancer and ultimately improve their overall survival. Docetaxel (DTX) represents the first-line of the antitumor agent that is used to treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ying, Guo, Mimi, Lin, Dingmei, Liang, Dajun, Zhao, Ling, Zhao, Ruizhi, Wang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284156/
https://www.ncbi.nlm.nih.gov/pubmed/34263685
http://dx.doi.org/10.1080/10717544.2021.1951894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284156/
https://www.ncbi.nlm.nih.gov/pubmed/34263685
http://dx.doi.org/10.1080/10717544.2021.1951894

Ejemplares similares